WO2002036518A1 - Porous calcium phosphate cement - Google Patents

Porous calcium phosphate cement Download PDF

Info

Publication number
WO2002036518A1
WO2002036518A1 PCT/US2001/031480 US0131480W WO0236518A1 WO 2002036518 A1 WO2002036518 A1 WO 2002036518A1 US 0131480 W US0131480 W US 0131480W WO 0236518 A1 WO0236518 A1 WO 0236518A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
carbonate
set forth
treatment material
calcium
Prior art date
Application number
PCT/US2001/031480
Other languages
French (fr)
Inventor
Brian Edwards
Paul Higham
Joseph Zitelli
Original Assignee
Howmedica Osteonics Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howmedica Osteonics Corp. filed Critical Howmedica Osteonics Corp.
Priority to DE60115703T priority Critical patent/DE60115703T2/en
Priority to JP2002539282A priority patent/JP2004512880A/en
Priority to CA002394100A priority patent/CA2394100C/en
Priority to AU96730/01A priority patent/AU777599B2/en
Priority to EP01977625A priority patent/EP1335757B1/en
Publication of WO2002036518A1 publication Critical patent/WO2002036518A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/34Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
    • C04B28/344Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition solely as one or more phosphates
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/02Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by adding chemical blowing agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Definitions

  • This invention relates to calcium phosphate cements which set after the mixing of a powdered calcium and phosphate source in an aqueous solution to form hydroxyapatite (HA). More particularly, it relates to the addition of citric acid and sodium bicarbonate to produce carbon dioxide during the setting of a calcium phosphate cement, thereby introducing macroporosity into the structure.
  • bone cements and bone filler materials which harden or set have an interconnected porosity (macroporosity) throughout their structure after hardening.
  • This interconnected porosity if of sufficient pore size, allows for vascularization and tissue ingrowth to occur into the structure. Pores greater than 70 microns in diameter have been found to allow tissue ingrowth. This tissue ingrowth can be encouraged by coating or filling the pores with osteoinductive or osteoconductive factors such as bone morphogenic proteins (BMPs). Such factors are well known to those skilled in the art.
  • Other therapeutic agents such as antibiotics or chemo-therapeutic agents may be introduced into the porosity by adding them to the liquid or powder.
  • porosity has been generated by including fillers which are soluble in physiological fluids or which are resorbed after implantation. These systems have the disadvantage that the porosity only occurs after implantation and thus the pores cannot be filled with growth factors or other therapeutic agents prior to implantation.
  • up to 50 volume percent of resorbable filler must be added to the calcium and phosphate source precursor powdered material. This sometimes adversely affects material properties and reduces the amount of hydroxyapatite formed in the reaction of the calcium and phosphate precursors.
  • foaming agents such as citrimide BP which reduce the surface tension of the water have been used.
  • U.S. patent 5,820,632 to Constantz et al. relates to a calcium phosphate cement wherein when a porous structure is desired, various additives may be included which may be leached out so as to provide for porosity in the cement. This porosity is in addition to any porosities achieved with a release of gas formed during the reaction to produce the product. Constantz et al. teaches including aggregates of soluble materials generally above 25 volume percent to develop sufficient interconnected porosity to foster bony ingrowth with the volume of aggregate normally being less than 50 volume percent. Specifically, Constantz et al. suggests the addition of calcium chloride and sodium or potassium hydroxide which are water soluble and will be leached out to provide the porosity.
  • U.S. patent 5,525,148 to Chow et al. teaches the use of pore forming agents that are preferably, substantially insoluble in the cement itself and can be removed by either resorbtion into body tissue, dissolution into physiological solutions, dissolution in solvents or heating after the cement has hardened.
  • the pore forming agents taught by Chow et al. include sugar, sodium bicarbonate and phosphate salts.
  • a method for making a porous cement which sets to hydroxyapatite at ambient temperatures comprising mixing a powder comprising a calcium source, a phosphate source and a base with a liquid comprising an aqueous solution containing an acid wherein the calcium source and the phosphate source mix with the liquid component to form hydroxyapatite and the acid and base react to form carbon dioxide producing an interconnected porosity in the material.
  • the base is a carbonate selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate and calcium bicarbonate or a combination thereof.
  • the preferred acid is selected from the group consisting of citric acid, malic acid, fumaric acid, lactic acid, succinic acid and orthophosphoric acid or a combination thereof.
  • the preferred calcium and phosphate sources may be selected from the group consisting of terra-calcium phosphate, dicalcium phosphate, tricalcium phosphate and monocalcium phosphate.
  • the preferred ratio of acid to carbonate to produce a neutral pH has been found to be about 0.7 grams of acid to about 1.0 grams of carbonate.
  • the preferred ratio of the acid and carbonate to the combined powdered and liquid components forming the calcium phosphate cement is. about 10 to 20% by weight.
  • FIG. 1 is a cross-sectional micrograph of the porous bone cement of the present invention formed at liquid to powder ratio of .25 and an acid/base weight percent of 10%; and FIG. 2 is a cross-sectional micrograph of the porous bone cement of the present invention made from a liquid to powder ratio of .35 and an weight percent of acid to base of 20%.
  • This invention relates to calcium phosphate cements of the type taught in Brown and Chow, U.S. reissued patents RE 33,161 and RE 33,221 and in Chow and Takagi U.S. patent 5,525,148 and in Constantz U.S. patent 4,880,610, the teachings of which are incorporated herein by reference.
  • the method for porosity generation of the present invention is the addition of citric acid monohydrate in an aqueous mixture and sodium bicarbonate in powder form into the calcium phosphate powder mixture taught by the patents referred to above in which tetra-calcium phosphate and dicalcium phosphate powders are mixed with a liquid component which may be dionized water or a sodium phosphate solution.
  • the ratio of acid to base is 1 gram of a base such as sodium bicarbonate to 0.7 grams of an acid such as citric acid.
  • the sodium bicarbonate powder is mixed with the tetra-calcium phosphate and dicalcium phosphate powders with the resultant mixture then being combined with an aqueous liquid into which the citric acid has been added as a liquid.
  • the preferred liquid to powder ratio is between about .25 to .35.
  • the preferred weight percent of the acid/base to the liquid and powder combination is between about 10 to about 20 weight percent.
  • the ratio of acid to base was determined by reacting various ratios of each component in 10ml of water. The ratio that left the pH of the water unchanged after completion of the reaction was chosen to be mixed with the powdered tetra- calcium phosphate and dicalcium phosphate combination. It was determined that the ratio of 0.7 grams of citric acid to 1.0 grams of sodium bicarbonate produced a neutral pH.
  • Sodium bicarbonate was mixed as a powder into the powdered tetra-calcium phosphate and dicalcium phosphate.
  • Citric acid monohydrate was mixed into the deionized water liquid component.
  • the acid/base ratio (A/B) was 0.7 grams of citric acid to 1.0 grams of sodium bicarbonate.
  • a series of tests were performed in which the citric acid was added to deionized water and also was added to a .25 M sodium phosphate solution.
  • Various liquid/powder (1/p) ratios were evaluated. Although the acid used was in solution, the invention would work equally well if an acid in dry form (free of uncombined water) was used as part of the powdered component.
  • specimen number 10 and specimen number 11 produced the most acceptable levels of hydroxyapatite of 67 and 69%, respectively and greater than 35% porosity.
  • the pore sizes were between 440 and 580 microns. Pore sizes of at least 70 microns are desirable.
  • Specimen 10 include a liquid to powder to ratio of .35 and 20% by weight of the citric acid and sodium bicarbonate added in with the aforementioned ratio of .7 grams of the citric acid to every gram of sodium bicarbonate and had a 35% porosity with 67% HA.
  • specimen 11 which utilized a .25 liquid to powder ratio and a 10% acid base weight ratio produced a 47% porosity with 69% HA.
  • the method of producing a porous structure in a bone cement or filler could be utilized on any bone cement type such as a glass ionomer cement, poly (propylene fumarate) or a methacrylate cement where liquid and powdered components are mixed.
  • a methacrylate cement is made by reacting a liquid methacrylate monomer with a powdered methacrylate polymer. Again, the powdered sodium bicarbonate is added to the powdered component and an acid source, such as citric acid, is added to the liquid component.
  • any gas producing chemical reaction could be used to form the pores.
  • the acid in the liquid component it is possible to add the acid in a crystalline form as a solid component.
  • An example of such an acid material is phosphoric acid free of uncombined water.
  • the calcium phosphate materials mixed without the gas forming citric acid and sodium bicarbonate components had a macroporosity of only 4%.
  • the pore size can be controlled by using less liquid in the liquid to powder ratio and/or less of the acid-base mixture to obtain smaller pore sizes. Conversely, more liquid or a higher weight percent of acid-base results in more porosity and larger pores.
  • FIGS. 1 and 2 show the porous bone cements of Examples 11 and 10 respectively, showing average pore sizes greater than 70 microns.

Abstract

A kit and a method for making a porous cement which self sets to hydroxyapatite and has an interconnected porosity is produced by mixing a calcium source and a phosphate source with a carbonate source and mixing this powdered component with a liquid component having an acid component. The liquid component comprises water on an aqueous solution containing an acid. The acid and the carbonate react to form carbon dioxide thereby producing an interconnected porosity in the normally solid self-hardening bone cement. The method requires only a relatively low weight percent of the acid and base to be mixed with the liquid and powder cement components.

Description

POROUS CALCIUM PHOSPHATE CEMENT FIELD OF THE INVENTION
This invention relates to calcium phosphate cements which set after the mixing of a powdered calcium and phosphate source in an aqueous solution to form hydroxyapatite (HA). More particularly, it relates to the addition of citric acid and sodium bicarbonate to produce carbon dioxide during the setting of a calcium phosphate cement, thereby introducing macroporosity into the structure. BACKGROUND OF THE INVENTION
It is sometimes desired that bone cements and bone filler materials which harden or set have an interconnected porosity (macroporosity) throughout their structure after hardening. This interconnected porosity, if of sufficient pore size, allows for vascularization and tissue ingrowth to occur into the structure. Pores greater than 70 microns in diameter have been found to allow tissue ingrowth. This tissue ingrowth can be encouraged by coating or filling the pores with osteoinductive or osteoconductive factors such as bone morphogenic proteins (BMPs). Such factors are well known to those skilled in the art. Other therapeutic agents such as antibiotics or chemo-therapeutic agents may be introduced into the porosity by adding them to the liquid or powder.
In the past, porosity has been generated by including fillers which are soluble in physiological fluids or which are resorbed after implantation. These systems have the disadvantage that the porosity only occurs after implantation and thus the pores cannot be filled with growth factors or other therapeutic agents prior to implantation. In addition, to form the required interconnected porosity, up to 50 volume percent of resorbable filler must be added to the calcium and phosphate source precursor powdered material. This sometimes adversely affects material properties and reduces the amount of hydroxyapatite formed in the reaction of the calcium and phosphate precursors.
Also, foaming agents, such as citrimide BP which reduce the surface tension of the water have been used. However, this produces unwanted ammonium compounds when used in vivo.
U.S. patent 5,820,632 to Constantz et al. relates to a calcium phosphate cement wherein when a porous structure is desired, various additives may be included which may be leached out so as to provide for porosity in the cement. This porosity is in addition to any porosities achieved with a release of gas formed during the reaction to produce the product. Constantz et al. teaches including aggregates of soluble materials generally above 25 volume percent to develop sufficient interconnected porosity to foster bony ingrowth with the volume of aggregate normally being less than 50 volume percent. Specifically, Constantz et al. suggests the addition of calcium chloride and sodium or potassium hydroxide which are water soluble and will be leached out to provide the porosity.
U.S. patent 5,525,148 to Chow et al. teaches the use of pore forming agents that are preferably, substantially insoluble in the cement itself and can be removed by either resorbtion into body tissue, dissolution into physiological solutions, dissolution in solvents or heating after the cement has hardened. The pore forming agents taught by Chow et al. include sugar, sodium bicarbonate and phosphate salts.
Thus, there is a need to find a simple way of forming an interconnected porosity of sufficient pore size during cement hardening or setting and which avoids adding large amounts of filler to the cement. It has been found that the production or introduction of sufficient amounts of carbon dioxide gas during the reaction of the calcium and phosphate precursors to form HA produces the desired porosity.
It has been found that adding sodium bicarbonate and citric acid to the calcium and phosphate precursors to the formation of hydroxyapatite with a ratio of these acid and alkaline components selected such that the final result of their reaction does not change the pH of the aqueous solution, that a final cement having the desired porosity, sufficient hydroxyapatite and sufficient physical properties are produced. SUMMARY OF THE INVENTION It is an object of this invention to provide a method of preparing calcium phosphate cement compositions, which self-harden substantially to hydroxyapatite at ambient temperatures when in contact with an aqueous medium, comprising, combining one or more sparingly soluble calcium phosphates along with an acid and base to produce a set material having an interconnected porosity.
It is another object of the invention to provide an acid and base which react to form carbon dioxide during the setting process of the calcium phosphate cement compositions and which does not alter the final pH of the mixture of the one or more sparingly soluble calcium phosphate powders when combined with the aqueous medium normally added thereto.
These and other objects of the invention are provided by a method for making a porous cement which sets to hydroxyapatite at ambient temperatures comprising mixing a powder comprising a calcium source, a phosphate source and a base with a liquid comprising an aqueous solution containing an acid wherein the calcium source and the phosphate source mix with the liquid component to form hydroxyapatite and the acid and base react to form carbon dioxide producing an interconnected porosity in the material. In the preferred embodiment, the base is a carbonate selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate and calcium bicarbonate or a combination thereof. The preferred acid is selected from the group consisting of citric acid, malic acid, fumaric acid, lactic acid, succinic acid and orthophosphoric acid or a combination thereof. The preferred calcium and phosphate sources may be selected from the group consisting of terra-calcium phosphate, dicalcium phosphate, tricalcium phosphate and monocalcium phosphate. The preferred ratio of acid to carbonate to produce a neutral pH has been found to be about 0.7 grams of acid to about 1.0 grams of carbonate. The preferred ratio of the acid and carbonate to the combined powdered and liquid components forming the calcium phosphate cement is. about 10 to 20% by weight.
These and other objects and advantages of the present invention will become apparent from the following description of the accompanying drawings, which disclose several embodiments of the invention. It is to be understood that the drawings are to be used for the purposes of illustration only and not as a definition of the invention. BRIEF DESCRIPTION OF THE DRAWINGS
In the drawings wherein similar reference characters denote similar elements throughout the several views, in which:
FIG. 1 is a cross-sectional micrograph of the porous bone cement of the present invention formed at liquid to powder ratio of .25 and an acid/base weight percent of 10%; and FIG. 2 is a cross-sectional micrograph of the porous bone cement of the present invention made from a liquid to powder ratio of .35 and an weight percent of acid to base of 20%. DESCRIPTION OF THE PREFERRED EMBODIMENTS
This invention relates to calcium phosphate cements of the type taught in Brown and Chow, U.S. reissued patents RE 33,161 and RE 33,221 and in Chow and Takagi U.S. patent 5,525,148 and in Constantz U.S. patent 4,880,610, the teachings of which are incorporated herein by reference.
The method for porosity generation of the present invention is the addition of citric acid monohydrate in an aqueous mixture and sodium bicarbonate in powder form into the calcium phosphate powder mixture taught by the patents referred to above in which tetra-calcium phosphate and dicalcium phosphate powders are mixed with a liquid component which may be dionized water or a sodium phosphate solution. In the preferred embodiment, the ratio of acid to base is 1 gram of a base such as sodium bicarbonate to 0.7 grams of an acid such as citric acid. In the preferred embodiment, the sodium bicarbonate powder is mixed with the tetra-calcium phosphate and dicalcium phosphate powders with the resultant mixture then being combined with an aqueous liquid into which the citric acid has been added as a liquid. The preferred liquid to powder ratio is between about .25 to .35. The preferred weight percent of the acid/base to the liquid and powder combination is between about 10 to about 20 weight percent. Example:
The ratio of acid to base (citric acid to sodium bicarbonate) was determined by reacting various ratios of each component in 10ml of water. The ratio that left the pH of the water unchanged after completion of the reaction was chosen to be mixed with the powdered tetra- calcium phosphate and dicalcium phosphate combination. It was determined that the ratio of 0.7 grams of citric acid to 1.0 grams of sodium bicarbonate produced a neutral pH.
Sodium bicarbonate was mixed as a powder into the powdered tetra-calcium phosphate and dicalcium phosphate. Citric acid monohydrate was mixed into the deionized water liquid component. The acid/base ratio (A/B) was 0.7 grams of citric acid to 1.0 grams of sodium bicarbonate. A series of tests were performed in which the citric acid was added to deionized water and also was added to a .25 M sodium phosphate solution. Various liquid/powder (1/p) ratios were evaluated. Although the acid used was in solution, the invention would work equally well if an acid in dry form (free of uncombined water) was used as part of the powdered component.
After twenty-four (24) hours of setting at 37°C in greater than 95% relative humidity, each cement specimen was dried to stop the reaction. X-ray diffraction measurements were made to determine the percent conversion to hydroxyapatite (HA) and the cement was sectioned to reveal the porosity. Figures 1 and 2 show the sections of two samples for illustrative purposes only.
The results of those tests are summarized in Table I. From this table, it can be seen that the specimen number 10 and specimen number 11 produced the most acceptable levels of hydroxyapatite of 67 and 69%, respectively and greater than 35% porosity. The pore sizes were between 440 and 580 microns. Pore sizes of at least 70 microns are desirable. Specimen 10 include a liquid to powder to ratio of .35 and 20% by weight of the citric acid and sodium bicarbonate added in with the aforementioned ratio of .7 grams of the citric acid to every gram of sodium bicarbonate and had a 35% porosity with 67% HA. Likewise, specimen 11 which utilized a .25 liquid to powder ratio and a 10% acid base weight ratio produced a 47% porosity with 69% HA. While the Example deals with a calcium phosphate bone material, the method of producing a porous structure in a bone cement or filler could be utilized on any bone cement type such as a glass ionomer cement, poly (propylene fumarate) or a methacrylate cement where liquid and powdered components are mixed. A methacrylate cement is made by reacting a liquid methacrylate monomer with a powdered methacrylate polymer. Again, the powdered sodium bicarbonate is added to the powdered component and an acid source, such as citric acid, is added to the liquid component. Also, any gas producing chemical reaction could be used to form the pores. Rather than having the acid in the liquid component, it is possible to add the acid in a crystalline form as a solid component. An example of such an acid material is phosphoric acid free of uncombined water.
It is also possible to introduce carbon dioxide, nitric oxide or an inert gas such as nitrogen or helium directly into the setting cement mixture to form the porosity. This can be accomplished through a port in the mixing container.
TABLE I
Cements Mixed Using Deionized Water
*aps = average pore size
specimen wt% A/B % %converted
# in mix porosity to HA comments
1 J25 20 12 31
2 .188 5 13 ~ 109 μm aps*
3 J88 20 20 45
4 .25 2 8 37
5 .25 5 36 50 580 μm aps*
specimen wt% A/B % %converted
# 1/E in mix porositv to HA comments
6 .35 10 36 64
7 .25 20 32 55 440 μm aps*
8 .25 30 51 66
9 .25 40 51 63 Cements Mixed With Sodium Phosphate Solution specimen wt% A/B % %converted
# l/p_ in mix porosity to HA
10 .35 20 35 67
11 .25 10 47 69
12 .30 10 26 58
The calcium phosphate materials mixed without the gas forming citric acid and sodium bicarbonate components had a macroporosity of only 4%.
The pore size can be controlled by using less liquid in the liquid to powder ratio and/or less of the acid-base mixture to obtain smaller pore sizes. Conversely, more liquid or a higher weight percent of acid-base results in more porosity and larger pores. FIGS. 1 and 2 show the porous bone cements of Examples 11 and 10 respectively, showing average pore sizes greater than 70 microns.
While several examples of the present invention have been described, it is obvious that many changes and modifications may be made thereunto, without departing from the spirit and scope of the invention.

Claims

CLAIMS:
1. A kit for producing a self-setting bone cement comprising: a liquid component containing a first reaction composition; an acid source selected from the group consisting of citric acid, malic acid, phosphoric acid, fumaric acid, lactic acid, succinic acid and a combination thereof; and a powdered composition containing a second reaction composition for reacting with said first reaction component to form said cement and containing a carbonate selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and a combination thereof.
2. The kit as set forth in claim 1, wherein the ratio of the weights of acid to the carbonate is chosen such that the final result of their reaction does not change the final pH of the mixture of the other powdered and liquid components.
3. The kit as set forth in claim 2, wherein the weight ratio of the acid to carbonate is about 0.7 grams of acid to about 1.0 grams of carbonate.
4. The kit as set forth in claim 1, wherein the weight ratio of the acid and carbonate to the first and second reaction components forming the cement is about 10 to 20%.
5. The kit as set forth in claim 1, wherein the first reaction composition is selected from the group consisting of water, deionized water an aqueous solution of sodium phosphate and a combination thereof.
6. The kit as set forth in claim 1, wherein said second reaction component is comprised of a calcium source and a phosphate source.
7. The kit as set forth in claim 6, wherein the calcium and phosphate sources are selected from the group consisting of tetra-calcium phosphate, dicalcium phosphate, tricalcium phosphate and monocalcium phosphate.
8. A method for making a porous cement which self sets to hydroxyapatite as the predominant product at ambient temperatures comprising: mixing a calcium source, a phosphate source and a base to form a powdered component; mixing a liquid component comprising an aqueous solution containing an acid; and mixing said powdered component and said liquid component causing said acid and base to react to form a gas while said calcium and phosphate source combine to form the hydroxyapatite cement.
9. The method as set forth in claim 8, wherein the base is a carbonate selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and a combination thereof.
10. The method as set forth in claim 9, wherein the acid is selected from the group consisting of citric acid, malic acid, phosphoric acid, fumaric acid, lactic acid, succinic acid and a combination thereof.
11. The method as set forth in claim 8, wherein said acid and base react to form carbon dioxide.
12. A bone treatment material comprising: a powdered component, a liquid component and a gas source, said powdered component and said liquid component reacting to form a settable bone treatment material, said gas source present while the reaction is occurring to form a porous structure in said set bone treatment material.
13. The bone treatment material of claim 12, wherein the powdered component is a calcium and phosphate source and the liquid component is an aqueous solution.
14. The bone treatment material as set forth in claim 13, wherein the sources of calcium and phosphate are tetra-calcium phosphate and dicalcium phosphate.
15. The bone treatment material as set forth in claim 12, wherein the gas source is selected from the group consistmg of carbon dioxide, nitric oxide and a combination thereof.
16. The bone treatment material as set forth in claim 15, wherein the carbon dioxide is produced by an acid/base reaction.
17. The bone treatment material as set forth in claim 16, wherein the acid is selected from the group consisting of citric acid, malic acid, phosphoric acid, fumaric acid, lactic acid, succinic acid and a combination thereof.
18. The bone treatment material as set forth in claim 17, wherein the base is selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and a combination thereof.
19. The bone treatment material of claim 18, wherein the ratio weights of acid to the carbonate is chosen such that the final result of their reaction does not change the final pH of the mixture of the other powdered and liquid components.
20. The bone treatment material of claim 19, wherein the weight ratio of the acid to carbonate is about 0.7 grams of acid to about 1.0 grams of carbonate. .
21. The bone treatment material of claim 19, wherein the weight ratio of the acid and carbonate to the liquid and powdered components forming the cement is 10 to 20%.
22. The bone treatment material as set forth in claim 21, wherein the gas source is carbon dioxide.
23. The bone treatment material as set forth in claim 22, wherein the carbon dioxide is produced by an acid/base reaction.
24. The bone treatment material as set forth in claim 23, wherein the acid is selected from the group consisting of citric acid, malic acid, phosphoric acid, fumaric acid, lactic acid, succinic acid and a combination thereof.
25. The bone treatment material as set forth in claim 24, wherein the base is selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and a combination thereof.
26. The bone treatment material of claim 25, wherein the ratio of the weights of acid to the carbonate are chosen such that the final result of their reaction does not change the final pH of the mixture of the other powdered and liquid components.
27. The bone treatment material of claim 26, wherein the weight ratio of the acid to carbonate is about 0.7 grams of acid to about 1.0 grams of carbonate.
28. The bone treatment material of claim 27, wherein the weight ratio of the acid and carbonate to the liquid and powdered components forming the cement is 10 to 20%.
29. The bone treatment material as set forth in claim 29, wherein the gas produces a cement having an average pore size of at least 70 microns after setting.
30. The bone treatment material as set forth in claim 29, wherein the gas produces a cement having an average pore size of between 440 microns and 580 microns after setting.
PCT/US2001/031480 2000-10-30 2001-10-10 Porous calcium phosphate cement WO2002036518A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE60115703T DE60115703T2 (en) 2000-10-30 2001-10-10 POROUS CALCIUM PHOSPHATE CEMENT
JP2002539282A JP2004512880A (en) 2000-10-30 2001-10-10 Porous calcium phosphate cement
CA002394100A CA2394100C (en) 2000-10-30 2001-10-10 Porous calcium phosphate cement
AU96730/01A AU777599B2 (en) 2000-10-30 2001-10-10 Porous calcium phosphate cement
EP01977625A EP1335757B1 (en) 2000-10-30 2001-10-10 Porous calcium phosphate cement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/699,662 US6547866B1 (en) 2000-10-30 2000-10-30 Porous calcium phosphate cement
US09/699,662 2000-10-30

Publications (1)

Publication Number Publication Date
WO2002036518A1 true WO2002036518A1 (en) 2002-05-10

Family

ID=24810331

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/031480 WO2002036518A1 (en) 2000-10-30 2001-10-10 Porous calcium phosphate cement

Country Status (7)

Country Link
US (2) US6547866B1 (en)
EP (1) EP1335757B1 (en)
JP (1) JP2004512880A (en)
AU (1) AU777599B2 (en)
CA (1) CA2394100C (en)
DE (1) DE60115703T2 (en)
WO (1) WO2002036518A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841897A1 (en) * 2002-07-08 2004-01-09 Rousselot Sas Production of apatitic cement useful for trapping pollutants comprises reacting dicalcium phosphate dihydrate with calcium carbonate in the presence of an activator
WO2006014886A2 (en) 2004-07-26 2006-02-09 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
EP1761472A2 (en) * 2004-02-10 2007-03-14 New York University Macroporous, resorbable and injectible calcium phosphate-based cements (mcpc) for bone repair, augmentation, regeneration, and osteoporosis treatment
WO2008089019A2 (en) * 2007-01-12 2008-07-24 Warsaw Orthopedic, Inc. System and method for forming porous bone filling material
EP1962716A2 (en) * 2005-12-06 2008-09-03 Etex Corporation Porous calcium phosphate bone material
WO2007145824A3 (en) * 2006-06-08 2009-01-22 Kyphon Sarl Self-foaming cement for void filling and/or delivery systems
US7651701B2 (en) 2005-08-29 2010-01-26 Sanatis Gmbh Bone cement composition and method of making the same
US7754005B2 (en) 2006-05-02 2010-07-13 Kyphon Sarl Bone cement compositions comprising an indicator agent and related methods thereof
US7758693B2 (en) 2002-06-07 2010-07-20 Kyphon Sarl Strontium-apatite cement preparations, cements formed therefrom, and uses thereof
US7968616B2 (en) 2008-04-22 2011-06-28 Kyphon Sarl Bone cement composition and method
CN101891174B (en) * 2009-03-11 2011-11-02 北京林业大学 Hydroxyapatite with hollow sphere structure and preparation method thereof
US8168692B2 (en) 2004-04-27 2012-05-01 Kyphon Sarl Bone substitute compositions and method of use
DE112010001636T5 (en) 2009-04-17 2012-06-21 Hoya Corp. Calcium phosphate cement composition and its bone prosthesis kit
DE112010001628T5 (en) 2009-04-17 2012-07-19 Hoya Corp. Calcium phosphate cement composition and its bone prosthesis kit
NL2007850C2 (en) * 2011-11-24 2013-05-27 Stichting Katholieke Univ Injectable calcium phosphate cement comprising glucono-delta-lactone.

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) * 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US6840995B2 (en) * 1999-07-14 2005-01-11 Calcitec, Inc. Process for producing fast-setting, bioresorbable calcium phosphate cements
US7270705B2 (en) * 1999-07-14 2007-09-18 Jiin-Huey Chern Lin Method of increasing working time of tetracalcium phosphate cement paste
US7094282B2 (en) * 2000-07-13 2006-08-22 Calcitec, Inc. Calcium phosphate cement, use and preparation thereof
US7169373B2 (en) * 1999-07-14 2007-01-30 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same
US6960249B2 (en) * 1999-07-14 2005-11-01 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
DK1223990T3 (en) * 1999-10-15 2004-11-29 Inst Genetics Llc Formulations of hyaluronic acid for delivery of osteogenic proteins
DE10032220A1 (en) * 2000-07-03 2002-01-24 Sanatis Gmbh Magnesium ammonium phosphate cements, their manufacture and use
US7156915B2 (en) * 2000-07-13 2007-01-02 Calcitec, Inc. Tetracalcium phosphate (TTCP) with surface whiskers and method of making same
US7204876B2 (en) * 2000-07-13 2007-04-17 Calcitec, Inc. Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
JP2004533276A (en) * 2001-01-25 2004-11-04 リジェネレーション テクノロジーズ インク. Injectable porous bone graft material
US20030216777A1 (en) * 2002-05-16 2003-11-20 Yin-Chun Tien Method of enhancing healing of interfacial gap between bone and tendon or ligament
US20040254668A1 (en) * 2003-06-16 2004-12-16 Jang Bor Z. Macro-porous hydroxyapatite scaffold compositions and freeform fabrication method thereof
US6994726B2 (en) * 2004-05-25 2006-02-07 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
TWI275386B (en) * 2003-08-05 2007-03-11 Cana Lab Corp Methods for preparing medical implants from calcium phosphate cement and medical implants
US7163651B2 (en) * 2004-02-19 2007-01-16 Calcitec, Inc. Method for making a porous calcium phosphate article
US7118705B2 (en) * 2003-08-05 2006-10-10 Calcitec, Inc. Method for making a molded calcium phosphate article
WO2005046440A2 (en) * 2003-11-07 2005-05-26 Calcitec, Inc. Spinal fusion procedure using an injectable bone substitute
US20060110422A1 (en) * 2004-11-19 2006-05-25 Tas Ahmet C Conversion of calcite powders into macro- and microporous calcium phosphate scaffolds for medical applications
US7312989B2 (en) * 2004-12-06 2007-12-25 Chenbro Micom Co., Ltd. Cooler
DE102004062739A1 (en) * 2004-12-27 2006-07-06 Degussa Ag Self-cleaning surfaces with protrusions formed by hydrophobic particles, with improved mechanical strength
US7713542B2 (en) * 2005-01-14 2010-05-11 Ada Foundation Three dimensional cell protector/pore architecture formation for bone and tissue constructs
EP2068950B1 (en) * 2006-09-21 2012-06-20 Kyphon SÀRL Diammonium phosphate and other ammonium salts and their use in preventing clotting
WO2008073190A2 (en) * 2006-11-03 2008-06-19 Kyphon Sarl Materials and methods and systems for delivering localized medical treatments
US8388626B2 (en) * 2006-11-08 2013-03-05 Warsaw Orthopedic, Inc. Methods of employing calcium phosphate cement compositions and osteoinductive proteins to effect vertebrae interbody fusion absent an interbody device
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8268010B2 (en) * 2007-01-12 2012-09-18 Warsaw Orthopedic, Inc. System and method for forming bone filling materials with microparticles
US8840618B2 (en) * 2007-01-12 2014-09-23 Warsaw Orthopedic, Inc. System and method for pressure mixing bone filling material
US8926623B2 (en) * 2007-01-12 2015-01-06 Warsaw Orthopedic, Inc. System and method for forming porous bone filling material
ITRM20070363A1 (en) 2007-06-27 2008-12-28 Univ Bologna Alma Mater POROUS SECTOR FROM CEMENTITIOUS MATERIAL OF CALCIUM PHOSPHATE AND ITS USE IN FLUID-SCALE EQUIPMENT
US20090036564A1 (en) * 2007-08-03 2009-02-05 Feng-Huei Lin Bio-Degenerable Bone Cement and Manufacturing Method thereof
KR101769805B1 (en) 2008-11-12 2017-08-21 스트리커 디벨롭먼트, 엘엘씨 Tetra calcium phosphate based organophosphorus compositions and methods
WO2010124110A1 (en) * 2009-04-22 2010-10-28 American Dental Association Foundation Dual-phase calcium phosphate cement composition
EP2512537B1 (en) 2009-12-18 2015-08-26 Howmedica Osteonics Corp. Dual paste direct injectable bone cement precursor systems and methods of making same
CA2798710C (en) 2010-05-11 2019-08-27 Venkat R. Garigapati Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
ES2714701T3 (en) 2010-11-10 2019-05-29 Stryker European Holdings I Llc Process for the preparation of a polymeric bone foam
CA2817584C (en) 2010-11-15 2018-01-02 Zimmer Orthobiologics, Inc. Bone void fillers
MY171424A (en) * 2011-01-27 2019-10-12 Sirim Berhad Composition containing injectable self-hardened apatite cement
WO2012158527A2 (en) 2011-05-13 2012-11-22 Howmedica Osteonics Organophosphorous & multivalent metal compound compositions & methods
CN102552986B (en) * 2012-02-28 2013-12-18 河南科技大学 Method for preparing porous bone cement by using metal porogen
US9820791B2 (en) 2014-08-22 2017-11-21 Kyphon SÀRL Methods of filling bone using bone cement mixing and delivery devices
US9820792B2 (en) 2014-08-22 2017-11-21 Kyphon SÀRL Bone cement mixing and delivery device
US11020160B2 (en) * 2016-03-21 2021-06-01 Warsaw Orthopedic, Inc. Surgical injection system and method
JP6807099B2 (en) * 2016-09-07 2021-01-06 公立大学法人大阪 Kits for producing bioactive cement pastes and bioactive cements, bioactive cement pastes and methods for producing them

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180426A (en) * 1987-12-28 1993-01-19 Asahi Kogaku Kogyo K.K. Composition for forming calcium phosphate type setting material and process for producing setting material
JPH0630985A (en) * 1992-06-01 1994-02-08 Nitta Gelatin Inc Hardenable material and porous material for medical treatment and dentistry
US5336264A (en) * 1988-04-20 1994-08-09 Norian Corporation Situ prepared calcium phosphate composition and method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33221A (en) * 1861-09-03 Improvement in soap
JPS5171896A (en) * 1974-12-20 1976-06-22 Kinto Kk TANSANAPATAITOKEIRINKOSEKINO SHORIHO
USRE33221E (en) 1982-04-29 1990-05-22 American Dental Association Health Foundation Dental restorative cement pastes
USRE33161E (en) 1982-04-29 1990-02-06 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
US5047031A (en) * 1988-04-20 1991-09-10 Norian Corporation In situ calcium phosphate minerals method
DE4124898A1 (en) * 1990-07-27 1992-01-30 Osaka Cement APETITE-CONTAINED TETRACALCIUM PHOSPHATE PARTICLES
US5149368A (en) * 1991-01-10 1992-09-22 Liu Sung Tsuen Resorbable bioactive calcium phosphate cement
EP0520690B1 (en) 1991-06-26 1995-11-02 Nitta Gelatin Inc. Calcium phosphate type hardening material for repairing living hard tissue
US5525148A (en) 1993-09-24 1996-06-11 American Dental Association Health Foundation Self-setting calcium phosphate cements and methods for preparing and using them
JPH1036106A (en) * 1996-07-26 1998-02-10 Taihei Kagaku Sangyo Kk Porous bulk apatite carbonate and its production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180426A (en) * 1987-12-28 1993-01-19 Asahi Kogaku Kogyo K.K. Composition for forming calcium phosphate type setting material and process for producing setting material
US5336264A (en) * 1988-04-20 1994-08-09 Norian Corporation Situ prepared calcium phosphate composition and method
JPH0630985A (en) * 1992-06-01 1994-02-08 Nitta Gelatin Inc Hardenable material and porous material for medical treatment and dentistry

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI [online] XP002906642, Database accession no. 1994-079343 *
See also references of EP1335757A4 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758693B2 (en) 2002-06-07 2010-07-20 Kyphon Sarl Strontium-apatite cement preparations, cements formed therefrom, and uses thereof
US8715410B2 (en) 2002-06-07 2014-05-06 Warsaw Orthopedic, Inc. Strontium-apatite cement preparation cements formed therefrom, and use thereof
FR2841897A1 (en) * 2002-07-08 2004-01-09 Rousselot Sas Production of apatitic cement useful for trapping pollutants comprises reacting dicalcium phosphate dihydrate with calcium carbonate in the presence of an activator
EP1761472A2 (en) * 2004-02-10 2007-03-14 New York University Macroporous, resorbable and injectible calcium phosphate-based cements (mcpc) for bone repair, augmentation, regeneration, and osteoporosis treatment
EP1761472A4 (en) * 2004-02-10 2010-01-20 Univ New York Macroporous, resorbable and injectible calcium phosphate-based cements (mcpc) for bone repair, augmentation, regeneration, and osteoporosis treatment
US8168692B2 (en) 2004-04-27 2012-05-01 Kyphon Sarl Bone substitute compositions and method of use
WO2006014886A2 (en) 2004-07-26 2006-02-09 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
EP1771184A2 (en) * 2004-07-26 2007-04-11 Skeletal Kinetics LLC Calcium phosphate cements and methods for using the same
US8419803B2 (en) 2004-07-26 2013-04-16 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
US10022471B2 (en) 2004-07-26 2018-07-17 Skeletal Kinetics, Llc Calcium phosphate cements and methods for using the same
EP1771184A4 (en) * 2004-07-26 2011-11-16 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
US7651701B2 (en) 2005-08-29 2010-01-26 Sanatis Gmbh Bone cement composition and method of making the same
US9089625B2 (en) 2005-08-29 2015-07-28 Kyphon Sarl Bone cement composition and method of making the same
EP1962716A2 (en) * 2005-12-06 2008-09-03 Etex Corporation Porous calcium phosphate bone material
EP2992855A1 (en) * 2005-12-06 2016-03-09 Etex Corporation Porous calcium phosphate bone material
EP1962716B1 (en) * 2005-12-06 2015-03-04 Etex Corporation Porous calcium phosphate bone material
AU2006322025B2 (en) * 2005-12-06 2013-08-15 Etex Corporation Porous calcium phosphate bone material
US7754005B2 (en) 2006-05-02 2010-07-13 Kyphon Sarl Bone cement compositions comprising an indicator agent and related methods thereof
US7507286B2 (en) 2006-06-08 2009-03-24 Sanatis Gmbh Self-foaming cement for void filling and/or delivery systems
WO2007145824A3 (en) * 2006-06-08 2009-01-22 Kyphon Sarl Self-foaming cement for void filling and/or delivery systems
WO2008089019A3 (en) * 2007-01-12 2009-08-27 Warsaw Orthopedic, Inc. System and method for forming porous bone filling material
WO2008089019A2 (en) * 2007-01-12 2008-07-24 Warsaw Orthopedic, Inc. System and method for forming porous bone filling material
US7968616B2 (en) 2008-04-22 2011-06-28 Kyphon Sarl Bone cement composition and method
CN101891174B (en) * 2009-03-11 2011-11-02 北京林业大学 Hydroxyapatite with hollow sphere structure and preparation method thereof
US8741053B2 (en) 2009-04-17 2014-06-03 Hoya Technosurgical Corporation Calcium phosphate cement composition and its kit for bone prosthesis
DE112010001628T5 (en) 2009-04-17 2012-07-19 Hoya Corp. Calcium phosphate cement composition and its bone prosthesis kit
DE112010001628B4 (en) 2009-04-17 2018-01-18 Hoya Corp. Calcium phosphate cement composition and its bone prosthesis kit
DE112010001636T5 (en) 2009-04-17 2012-06-21 Hoya Corp. Calcium phosphate cement composition and its bone prosthesis kit
WO2013077739A1 (en) * 2011-11-24 2013-05-30 Stichting Katholieke Universiteit Injectable calcium phosphate cement comprising gluconodelta- lactone
NL2007850C2 (en) * 2011-11-24 2013-05-27 Stichting Katholieke Univ Injectable calcium phosphate cement comprising glucono-delta-lactone.

Also Published As

Publication number Publication date
DE60115703T2 (en) 2006-10-05
AU777599B2 (en) 2004-10-21
JP2004512880A (en) 2004-04-30
US6670293B2 (en) 2003-12-30
CA2394100A1 (en) 2002-05-10
US6547866B1 (en) 2003-04-15
US20030019396A1 (en) 2003-01-30
AU9673001A (en) 2002-05-15
DE60115703D1 (en) 2006-01-12
EP1335757B1 (en) 2005-12-07
EP1335757A1 (en) 2003-08-20
CA2394100C (en) 2007-12-11
EP1335757A4 (en) 2003-08-20

Similar Documents

Publication Publication Date Title
CA2394100C (en) Porous calcium phosphate cement
EP1787626B1 (en) Injectable, self-setting calcium phosphate foam
EP2266634B1 (en) Rapid-hardening calcium phosphate cement compositions
US6495156B2 (en) Biocements having improved compressive strength
US5178845A (en) Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5820632A (en) Prepared calcium phosphate composition and method
US5053212A (en) Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US6002065A (en) Kits for preparing calcium phosphate minerals
WO2010119897A1 (en) Calcium phosphate cement composite for bone filling, and kit thereof
US7381262B2 (en) Method of preparing porous calcium phosphate granules
CA2088169C (en) Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US8540815B2 (en) Preparation for magnesium ammonium phosphate cements
Walsh et al. Preparation of a bone-like apatite foam cement
US20180264167A1 (en) Cement-forming compositions, apatite cements, implants and methods for correcting bone defects
Siek et al. Biodegradable cement type bone implant materials based on calcium phosphates and calcium sulphate
JPH0734817B2 (en) Medical and dental curable and porous materials
JPH0588623B2 (en)
JPH0533635B2 (en)
JPH0536064B2 (en)
JPH03242364A (en) Production of calcium phosphate-based biomaterial

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2394100

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001977625

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 96730/01

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 539282

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2001977625

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 96730/01

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001977625

Country of ref document: EP